Basic Information
RNALocate ID: | RLID-D:11000051 |
RNA Symbol: | hsa-miR-181c-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-181c-5p |
RNA ID: | miRBase:MIMAT0000258 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | B lymphoblastoid cells|Endothelial cells |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001631 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001632 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001633 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11001419 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11001420 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001421 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11001422 | Exosome | Brain tissue | 23382797 |
RLID:11001423 | Exosome | Plasma | 23663360 |
RLID:11001424 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11001425 | Microvesicle | Cerebrospinal fluid | 24797360 |
RLID-D:11000320 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-181c-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-19991 |
MNDR | hsa-miR-181c-5p | Medulloblastoma | MNDR-E-MI-19992 |
MNDR | hsa-miR-181c-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-19993 |
MNDR | hsa-miR-181c-5p | Lymphoma | MNDR-E-MI-19994 |
MNDR | hsa-miR-181c-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-19995 |
MNDR | hsa-miR-181c-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-19996 |
MNDR | hsa-miR-181c-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-19997 |
MNDR | hsa-miR-181c-5p | Breast cancer luminal | MNDR-E-MI-19998 |
MNDR | hsa-miR-181c-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-19999 |
MNDR | hsa-miR-181c-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-20000 |
MNDR | hsa-miR-181c-5p | Dermatomyositis | MNDR-E-MI-20001 |
MNDR | hsa-miR-181c-5p | Prostate cancer | MNDR-E-MI-20002 |
MNDR | hsa-miR-181c-5p | Gastric cancer | MNDR-E-MI-20003 |
MNDR | hsa-miR-181c-5p | Alzheimer disease | MNDR-E-MI-20004 |
MNDR | hsa-miR-181c-5p | Dysautonomia familial | MNDR-E-MI-20005 |
MNDR | hsa-miR-181c-5p | Seizures | MNDR-E-MI-20006 |
MNDR | hsa-miR-181c-5p | Leukemia | MNDR-E-MI-20007 |
MNDR | hsa-miR-181c-5p | Ataxia telangiectasia | MNDR-E-MI-20008 |
MNDR | hsa-miR-181c-5p | Huntington disease | MNDR-E-MI-20009 |
MNDR | hsa-miR-181c-5p | Cardiovascular disease | MNDR-E-MI-20010 |
MNDR | hsa-miR-181c-5p | Lung cancer | MNDR-E-MI-20011 |
MNDR | hsa-miR-181c-5p | Down syndrome | MNDR-E-MI-20012 |
MNDR | hsa-miR-181c-5p | Parkinson disease | MNDR-E-MI-20013 |
MNDR | hsa-miR-181c-5p | Breast cancer | MNDR-E-MI-20014 |
MNDR | hsa-miR-181c-5p | Thyroid cancer | MNDR-E-MI-20015 |
MNDR | hsa-miR-181c-5p | Pituitary neoplasms | MNDR-E-MI-20016 |
MNDR | hsa-miR-181c-5p | Pancreatic cancer | MNDR-E-MI-20017 |
MNDR | hsa-miR-181c-5p | Melanoma | MNDR-E-MI-20018 |
MNDR | hsa-miR-181c-5p | Nephroblastoma | MNDR-E-MI-20019 |
MNDR | hsa-miR-181c-5p | Colon cancer | MNDR-E-MI-20020 |
MNDR | hsa-miR-181c-5p | Colon adenocarcinoma | MNDR-E-MI-20021 |
MNDR | hsa-miR-181c-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-20022 |
MNDR | hsa-miR-181c-5p | Ovarian cancer | MNDR-E-MI-20023 |
MNDR | hsa-miR-181c-5p | Prostate adenocarcinoma | MNDR-E-MI-20024 |
MNDR | hsa-miR-181c-5p | Carcinoma ductal breast | MNDR-E-MI-20025 |
MNDR | hsa-miR-181c-5p | Glioblastoma | MNDR-E-MI-20026 |
MNDR | hsa-miR-181c-5p | Glioma | MNDR-E-MI-20027 |
MNDR | hsa-miR-181c-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-20028 |
MNDR | hsa-miR-181c-5p | Osteosarcoma | MNDR-E-MI-20029 |
MNDR | hsa-miR-181c-5p | Inclusion body myositis | MNDR-E-MI-20030 |
MNDR | hsa-miR-181c-5p | Gastric adenocarcinoma | MNDR-E-MI-20031 |
MNDR | hsa-miR-181c-5p | Cervical squamous cell carcinoma | MNDR-E-MI-20032 |
MNDR | hsa-miR-181c-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-20033 |
MNDR | hsa-miR-181c-5p | Lung squamous cell carcinoma | MNDR-E-MI-20034 |
MNDR | hsa-miR-181c-5p | Lung adenocarcinoma | MNDR-E-MI-20035 |
MNDR | hsa-miR-181c-5p | Thyroid carcinoma | MNDR-E-MI-20036 |
MNDR | hsa-miR-181c-5p | Bladder urothelial carcinoma | MNDR-E-MI-20037 |
MNDR | hsa-miR-181c-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-20038 |
MNDR | hsa-miR-181c-5p | Carcinoma renal cell | MNDR-E-MI-20039 |
MNDR | hsa-miR-181c-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-20040 |
MNDR | hsa-miR-181c-5p | Clear cell renal cell carcinoma | MNDR-E-MI-20041 |
MNDR | hsa-miR-181c-5p | Cholangiocarcinoma | MNDR-E-MI-20042 |
MNDR | hsa-miR-181c-5p | Esophageal cancer | MNDR-E-MI-20043 |
MNDR | hsa-miR-181c-5p | Synovial sarcoma | MNDR-E-MI-20044 |
MNDR | hsa-miR-181c-5p | Stomach carcinoma | MNDR-E-MI-20045 |
MNDR | hsa-miR-181c-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-20046 |
MNDR | hsa-miR-181c-5p | T acute lymphoblastic leukemia | MNDR-E-MI-20047 |
MNDR | hsa-miR-181c-5p | Acute t cell leukemia | MNDR-E-MI-20048 |
MNDR | hsa-miR-181c-5p | Breast invasive carcinoma | MNDR-E-MI-20049 |
MNDR | hsa-miR-181c-5p | Hepatocellular carcinoma | MNDR-E-MI-20050 |
MNDR | hsa-miR-181c-5p | Embryonal cancer | MNDR-E-MI-20051 |
MNDR | hsa-miR-181c-5p | B-cell lymphoma | MNDR-E-MI-20052 |
MNDR | hsa-miR-181c-5p | Rheumatoid arthritis | MNDR-E-MI-20053 |
MNDR | hsa-miR-181c-5p | T-cell leukemia | MNDR-E-MI-20054 |
MNDR | hsa-miR-181c-5p | Retinoblastoma | MNDR-E-MI-20055 |
MNDR | hsa-miR-181c-5p | Hodgkin lymphoma | MNDR-E-MI-20056 |
MNDR | hsa-miR-181c-5p | Burkitt lymphoma | MNDR-E-MI-20057 |
MNDR | hsa-miR-181c-5p | Dementia vascular | MNDR-E-MI-20058 |
MNDR | hsa-miR-181c-5p | Tonsil cancer | MNDR-E-MI-20059 |
MNDR | hsa-miR-181c-5p | Neuromyelitis optica | MNDR-E-MI-20060 |
MNDR | hsa-miR-181c-5p | Acute myelocytic leukemia | MNDR-E-MI-20061 |
MNDR | hsa-miR-181c-5p | Colorectal cancer | MNDR-E-MI-20062 |
MNDR | hsa-miR-181c-5p | Acute lymphocytic leukemia | MNDR-E-MI-20063 |
MNDR | hsa-miR-181c-5p | Inflammatory breast neoplasms | MNDR-E-MI-20064 |
MNDR | hsa-miR-181c-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-20065 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BCL2 | Homo sapiens | RR00219008 |
TOP